TF
CDMO

TimeScale Financial’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

TimeScale Financial’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-72
Closed -$1.38K – 670
2022
Q4 		$1.38K Hold
72
– – ﹤0.01% 481
2022
Q3 		$1K Hold
72
– – ﹤0.01% 532
2022
Q2 		$1K Hold
72
– – ﹤0.01% 504
2022
Q1 		$1K Hold
72
– – ﹤0.01% 513
2021
Q4 		$2K Buy
+72
New +$2.06K ﹤0.01% 462

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

TimeScale Financial's CDMO Position: Q1 2023 in Review

TimeScale Financial sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2023, closing a stake of 72 shares — an estimated $1.38K sold.

TimeScale Financial first reported a position in CDMO in Q4 2021 and held it in 5 quarters. The position peaked at $2K in Q4 2021. 168 funds tracked by Wall St. Rank hold CDMO as of Q1 2023.

  • TimeScale Financial reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • TimeScale Financial sold 72 Avid Bioservices, Inc. Common Stock shares in Q1 2023, an estimated $1.38K.
  • TimeScale Financial first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • TimeScale Financial's Avid Bioservices, Inc. Common Stock position peaked at $2K in Q4 2021.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2023.

Based on TimeScale Financial's 13F filing for Q1 2023, filed 24 Apr 2023.